CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 189 filers reported holding CARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,988 | -40.6% | 5,350 | 0.0% | 0.01% | -35.3% |
Q2 2023 | $15,141 | -42.4% | 5,350 | 0.0% | 0.02% | -45.2% |
Q1 2023 | $26,269 | -54.3% | 5,350 | 0.0% | 0.03% | -56.9% |
Q4 2022 | $57,459 | -17.9% | 5,350 | -28.1% | 0.07% | -28.0% |
Q3 2022 | $70,000 | -52.1% | 7,445 | -53.6% | 0.10% | -47.1% |
Q2 2022 | $146,000 | -25.1% | 16,040 | 0.0% | 0.19% | -18.2% |
Q1 2022 | $195,000 | -3.9% | 16,040 | -3.6% | 0.23% | +35.9% |
Q4 2021 | $203,000 | -15.1% | 16,643 | -0.6% | 0.17% | -8.1% |
Q2 2021 | $239,000 | -84.8% | 16,743 | -76.8% | 0.18% | -86.6% |
Q1 2021 | $1,570,000 | +27.6% | 72,315 | -11.0% | 1.38% | +29.9% |
Q4 2020 | $1,230,000 | -50.9% | 81,269 | -54.6% | 1.06% | -52.7% |
Q3 2020 | $2,507,000 | -18.8% | 179,197 | -0.7% | 2.25% | -26.9% |
Q2 2020 | $3,086,000 | +29.8% | 180,420 | +0.3% | 3.08% | -7.9% |
Q1 2020 | $2,377,000 | -19.9% | 179,954 | -2.2% | 3.35% | +19.6% |
Q4 2019 | $2,966,000 | +108.0% | 184,085 | +147.3% | 2.80% | +87.1% |
Q2 2018 | $1,426,000 | – | 74,445 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,568,057 | $70,005,000 | 74.08% |
Chescapmanager LLC | 1,203,055 | $23,604,000 | 2.80% |
Mesirow Financial Investment Management, Inc. | 29,821 | $585,000 | 2.32% |
DAFNA Capital Management LLC | 143,611 | $2,818,000 | 1.22% |
Opaleye Management Inc. | 200,000 | $3,924,000 | 1.09% |
SPHERA FUNDS MANAGEMENT LTD. | 303,930 | $5,963,000 | 0.54% |
DISCIPLINED GROWTH INVESTORS INC /MN | 852,892 | $16,734,000 | 0.29% |
DLD Asset Management, LP | 352,700 | $6,927,000 | 0.26% |
SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 54,984 | $1,079,000 | 0.18% |
B. Riley Wealth Management, Inc. | 33,755 | $662,000 | 0.12% |